FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

VALID Act Reintroduced

[ Price : $8.95]

Reps. Buschon and DeGette reintroduce the bipartisan VALID Act to reform the regulation of diagnostic tests by FDA and the Centers...

Research on Some Child Subjects Guidance

[ Price : $8.95]

FDA publishes a draft guidance to assist in understanding the processes used for the review of some research involving children as...

Align Global Gene, Cell Therapy Regulation: Marks

[ Price : $8.95]

CBER director Peter Marks says hed like to see aligned global regulations to boost commercialization for gene and cell therapies.

FDA Approves Abbotts Epic Max Heart Valve

[ Price : $8.95]

FDA approves an Abbott PMA supplement for Epic Max, a stented tissue valve to treat people with aortic regurgitation or stenosis.

FDA Converts 1 Keytruda Indication to Full Approval

[ Price : $8.95]

FDA converts Mercks Keytruda immunotherapy from accelerated to full approval for treating certain solid tumors

Califf Says GOP Budget Cuts Would Devastate FDA

[ Price : $8.95]

FDA commissioner Robert Califf tells House appropriators that reported plans on budget cuts of up to 22% being floated by Republic...

Clinical Hold Lifted on Vigil Neuros VGL101

[ Price : $8.95]

FDA lifts its partial clinical hold against Vigil Neuroscience and doses greater than 20 mg/kg for VGL101 in clinical trials in ce...

Panel to Vote on Non-RX Birth Control Pill

[ Price : $8.95]

Federal Register notice: FDA announces a 5/9 Advisory Committee meeting to discuss a non-RX birth control pill.

Advisory Committee on Epinephrine Nasal Spray

[ Price : $8.95]

Federal Register notice: FDA announces a 5/11 Pulmonary-Allergy Drugs Advisory Committee meeting to discuss an ARS Pharmaceuticals...

Device Cybersecurity Enforcement Discretion

[ Price : $8.95]

An FDA guidance says the agency will start to refuse to accept cyber device premarket submissions that dont contain required cyber...